GREATWALL vs Gin Hwa Biotech: monthly revenue

Monthly revenue and year-on-year change for GREATWALL (1210) and Gin Hwa Biotech (7806) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GREATWALL ━ Gin Hwa Biotech

0%+42%-29%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGREATWALLYoYGin Hwa BiotechYoY
Oct 2026NT$9.66 billion+14.6%NT$35.7 million-9.0%
Sep 2026NT$9.88 billion+13.2%NT$47.7 million+41.5%
Aug 2026NT$9.7 billion+13.4%NT$45.7 million-8.6%
Jul 2026NT$9.64 billion+21.5%NT$44 million+27.0%
Jun 2026NT$8.95 billion+12.2%NT$48.8 million+13.5%
May 2026NT$9.07 billion+10.2%NT$48.4 million-0.7%
Apr 2026NT$9.1 billion+4.3%NT$49 million+12.6%
Mar 2026NT$9.21 billion+5.0%NT$55.4 million-29.0%
Feb 2026NT$7.63 billion-5.7%NT$33.8 million-7.9%
Jan 2026NT$9.73 billion+12.0%NT$46.8 million+37.1%
Dec 2025NT$9.59 billion+4.6%NT$49.1 million+16.9%
Nov 2025NT$8.86 billion-1.2%NT$47.8 million+29.1%
Oct 2025NT$8.43 billion-2.0%NT$39.2 million+14.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16